FDA warns of another compounding pharmacy recall

by Matthew Perrone

BY MATTHEW PERRONE AP HEALTH WRITER WASHINGTON (AP) – The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients. The FDA said Wednesday that Clinical Specialties of Martinez, Ga. has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder in seniors.
The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since December 18, the FDA said in an online posting. Avastin is approved as a cancer drug, but it contains the same active ingredient as Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors. Repackaged injections of Avastin cost about $50, compared with $2,000 for Lucentis. A call placed to Clinical Specialties' lead pharmacist, Austin Gore, was not immediately returned Wednesday. Swiss drugmaker Roche has tried to discourage doctors from using Avastin for such unapproved uses. The company points out that Lucentis was specifically tested and formulated for use in the eye, and its price reflects the cost of that research and development. However, groups like the American Academy of Ophthalmologists say there is no detectable difference in outcomes for patients. More than half the injections given for macular generation in the U.S. are Avastin, according to the group. Age-related macular degeneration is the most common cause of blindness among older Americans, affecting about 2 million people in the U.S. over age 50. The condition causes new blood vessels to grow in the eye and leak blood and fluid, damaging the retina and distorting vision. In recent weeks the FDA has stepped up inspections of compounding pharmacies across a dozen states after a fungal meningitis outbreak last year tied to compounded drugs. A tainted steroid distributed by a Massachusetts-based compounding pharmacy killed 50 people and has sickened more than 720 nationwide. Many of the cases involved a rare form of meningitis tied to fungus found in the New England Compounding Center's facilities. The company has been shut down since the outbreak was discovered in September. ---- © 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


More Local

Ferst Foundation holds annual CCSS coin drive

In its eighth year of holding a coin drive to benefit the Ferst Foundation for Childhood Literacy, the Coweta County School System raised mo ... Read More


Movie studio decision could have 'chilling effect'

The recent release of “The Interview,” staring Seth Rogan and James Franco, has been cancelled due to threats of violence at the ... Read More


Senoia Redneck Gourmet to close

After six successful years, Casey Smith has decided to close the doors of the Redneck Gourmet in Senoia. As the owner of both the Newnan and ... Read More


One Roof to reopen Jan. 5 in new location

Friday was One Roof’s last day at its former location in the old Playtex plant on Temple Avenue. The store will reopen January 5 in t ... Read More


Boys & Girls Club

NHS student one of top youths of year

After months of preparation, a Newnan High School student was honored as one of the top youths of the year by the Boys and Girls Club of Met ... Read More

Thousands of lights on display on Hannah Road

It’s hard to miss the Bentons’ Christmas decorations as you’re driving down Hannah Road south of Newnan. The Bentons, who ... Read More